- Report
- July 2025
- 350 Pages
Global
From €4445EUR$4,949USD£3,797GBP
- Report
- March 2025
- 240 Pages
Global
From €4486EUR$4,995USD£3,832GBP
- Report
- July 2023
- 220 Pages
Global
€4307EUR$4,795USD£3,679GBP
- Report
- August 2025
- 150 Pages
Global
From €2838EUR$3,160USD£2,424GBP
€3548EUR$3,950USD£3,031GBP
- Report
- August 2025
- 150 Pages
Global
From €2838EUR$3,160USD£2,424GBP
€3548EUR$3,950USD£3,031GBP
- Report
- June 2023
- 146 Pages
Asia Pacific
From €3099EUR$3,450USD£2,647GBP
The Synthetic DNA market is a subset of the genomics industry that focuses on the production of artificial DNA molecules. Synthetic DNA is used in a variety of applications, including gene therapy, drug discovery, and agricultural biotechnology. It is also used in research to create new organisms, such as bacteria and viruses, and to modify existing organisms. Synthetic DNA is produced through a variety of methods, including chemical synthesis, enzymatic synthesis, and DNA cloning.
The Synthetic DNA market is expected to grow in the coming years due to increasing demand for gene therapy and drug discovery. Additionally, the development of new technologies, such as CRISPR-Cas9, is expected to drive growth in the market.
Some companies in the Synthetic DNA market include Twist Bioscience, GenScript, Integrated DNA Technologies, Eurofins Genomics, and ATUM. Show Less Read more